Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer
Herein, we assess the gene expression changes activated in thyroid tumors through a computational approach, using the MapReduce algorithm. Through this predictive analysis, we identified the TfR1 gene as a critical mediator of thyroid tumor progression. Then, we investigated the effect of TfR1 gene...
Main Authors: | Agata Campisi, Roberta Bonfanti, Giuseppina Raciti, Gabriele Bonaventura, Laura Legnani, Gaetano Magro, Marzio Pennisi, Giulia Russo, Maria Assunta Chiacchio, Francesco Pappalardo, Rosalba Parenti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770520300097 |
Similar Items
-
Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
by: Rosalba Parenti, et al.
Published: (2014-01-01) -
Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.
by: Rosalba Parenti, et al.
Published: (2014-01-01) -
Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland
by: PRK Bhargav, et al.
Published: (2011-01-01) -
Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland
by: Ganguly R, et al.
Published: (2010-04-01) -
Comment on: Synchronous occurrence of anaplastic, follicular, and papillary carcinoma with follicular adenoma in thyroid gland
by: Nazir Abdul Wasim, et al.
Published: (2011-01-01)